Short Androgen Suppression and Radiation Dose Escalation For Intermediate - and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991DocumentShort Androgen Suppression and Radiation Dose Escalation For Intermediate - and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991Added by mouna0 ratings0% found this document usefulSave Short Androgen Suppression and Radiation Dose Escalation For Intermediate - and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991 for later